Citation 190461

AHMAD, L: FOZIA: WAHEED, A: TAHIR, NB: RAIS, AK:. (2015). ANTI-INFLAMMATORY CONSTITUENTS FROM PEROVSKIA ATRIPLICIFOLIA. 53(11)

Citation Details

Title	ANTI-INFLAMMATORY CONSTITUENTS FROM PEROVSKIA ATRIPLICIFOLIA
Authors	AHMAD, L: FOZIA: WAHEED, A: TAHIR, NB: RAIS, AK:
Year	2015
Volume	53
Issue	11

Summary

Year: 2015

Journal: Unknown

Organisms and Their Experiments (1)

Perovskia atriplicifolia (LAMIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LEUKOTRIENE RELEASE INHIBITION	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
11	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORDETERMINATION IN BY POLAROGRAPHY	ABROTANONE	None
12	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORDETERMINATION IN BY POLAROGRAPHY	ABROTANDIOL	None
13	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORDETERMINATION IN BY POLAROGRAPHY	PINORESINOL,(+):	None
14	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORDETERMINATION IN BY POLAROGRAPHY	SYRINGARESINOL,(+):	None
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORDETERMINATION IN BY POLAROGRAPHY	LARICIRESINOL,(+):	None
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORDETERMINATION IN BY POLAROGRAPHY	TAXIRESINOL,(+):	None
21	LEUKOTRIENE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ABROTANONE	ACTIVE
22	LEUKOTRIENE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ABROTANDIOL	ACTIVE
23	LEUKOTRIENE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PINORESINOL,(+):	ACTIVE
24	LEUKOTRIENE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGARESINOL,(+):	ACTIVE
25	LEUKOTRIENE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LARICIRESINOL,(+):	ACTIVE
26	LEUKOTRIENE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIRESINOL,(+):	ACTIVE

Show SPARQL Queries (1)